−£170.98m
vs Dec 2023Active09429551Private limited companyLeatherhead
DALCOR PHARMA UK LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Dalcor Pharma UK Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DALCOR PHARMA UK LTD is an active private limited company (company number 09429551) incorporated on 9 February 2015, registered in Leatherhead. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£170.98m and cash of £338k, with 3 employees on average. Net assets fell 25% on the prior period (−£136.90m).
Peer position · net assets
By net assets it sits in the bottom quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
No active person with significant control is registered.
- Guy Desmarais
- owns 50–75% of shares
- holds 50–75% of voting rights
- Olivier Desmarais
- owns 50–75% of shares
- holds 50–75% of voting rights
- Andre Desmarais
- owns 50–75% of shares
- holds 50–75% of voting rights
- has significant influence or control
- France Chretien Desmarais
- owns 50–75% of shares
- holds 50–75% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 9 February 201511 yrs ago
- Next accounts due
- 30 September 202623 days overdue
- Confirmation statement due
- 23 February 2027in 123 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£338k
+24%vs Dec 2023Not reported
3
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£170.98m | £338k | — | £1.94m | — | −£34.07m | 3 |
| 31 December 2023 | −£136.90m | £273k | — | £3.38m | — | −£23.68m | 3 |
| 1 January 2023 | — | — | — | — | — | — | — |
Current ratio2.39Current assets ÷ creditors within one year
Cash per employee£113kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-170,979,104 at 31 December 2024
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.39
- Cash at bank of £50,000 or moreCash £337,848
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 9 February 2015
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 123 days
- Next accounts due23 days overdue
- Accounts period endNet liabilities £170.98m · small accounts
- Accounts period endNet liabilities £136.90m · small accounts
- Accounts period end
- Incorporated
08
Similar companies in Greater London
- FTRASHEED CONSULTING LTDBarking · inc. Jan 2015
- BIOSENZE CONSULTING LTDHarrow · inc. Dec 2014
- OXULAR LIMITEDUxbridge · inc. Nov 2014
- ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTDSidcup · inc. Oct 2014
- HASSAN SCIENCES LTDKent · inc. Jul 2015
- EY HOLDINGS LTDPotters Bar · inc. Sept 2015
All companies incorporated on 9 February 2015 · in Feb 2015.
09
Reminders for DALCOR PHARMA UK LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.